Nasdaq grants Entero Therapeutics extension to Oct 8, 2025 to meet minimum equity requirement

GridAI Technologies Corp.

Company received Nasdaq extension letter on June 25, 2025; deadline to regain compliance is October 8, 2025.
Must meet Nasdaq Rule 5550(b)(1) minimum stockholders' equity of $2.5 million.
As of Dec 31, 2024, stockholders' equity was negative $3.88 million, triggering the deficiency.
Failure to regain compliance may result in delisting, but appeal to a Nasdaq Hearing Panel is permitted.
No assurance that compliance will be achieved or listing maintained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.